Genetic evidence for the causal impact of immune cells on pancreatic neuroendocrine tumors and the mediating effects of cathepsins
- 6 August 2025
- journal article
- Published by Elsevier in Pancreatology
- Vol. 25 (6) , 930-938
Abstract
No abstract availableKeywords
Funding Information
- Guangzhou Municipal Science and Technology Project (2023A03J0194)
- National Natural Science Foundation of China (82002544)
- Natural Science Foundation of Guangdong Province (2023A1515010135)
This publication has 49 references indexed in Scilit:
- The impact of cathepsins on liver hepatocellular carcinoma: Insights from genetic and functional analysesGene, 2024
- Cathepsin H: Molecular characteristics and clues to function and mechanismBiochemical Pharmacology, 2023
- Meta‐analysis andMendelianrandomization: A reviewResearch Synthesis Methods, 2019
- Cathepsins: Proteases that are vital for survival but can also be fatalBiomedicine & Pharmacotherapy, 2018
- Trends in the Incidence, Prevalence, and Survival Outcomes in Patients With Neuroendocrine Tumors in the United StatesJAMA Oncology, 2017
- Exploring the rising incidence of neuroendocrine tumors: A population‐based analysis of epidemiology, metastatic presentation, and outcomesCancer, 2014
- Pancreatic cancer-associated Cathepsin E as a drug activatorJournal of Controlled Release, 2013
- Cathepsin E: A mini reviewBiochemical and Biophysical Research Communications, 2008
- Cysteine cathepsins: Cellular roadmap to different functionsBiochimie, 2008
- Endocrine tumours of the pancreasBest Practice & Research Clinical Gastroenterology, 2005